Vedolizumab Therapy for Refractory Eosinophilic Enteritis: A Case of Success

Inflamm Bowel Dis. 2023 Jan 5;29(1):e1-e2. doi: 10.1093/ibd/izac077.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Enteritis* / drug therapy
  • Gastritis*
  • Humans

Substances

  • vedolizumab
  • Antibodies, Monoclonal, Humanized

Supplementary concepts

  • Eosinophilic enteropathy